ALX ONCOLOGY HOLDINGS INC (ALXO) Net income 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$101.7MFY2025 · since FY2018: -$13.7M → -$101.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$101.7M | +24.6% |
| FY2024 | -$134.8M | +16.1% |
| FY2023 | -$160.8M | -30.2% |
| FY2022 | -$123.5M | -47.9% |
| FY2021 | -$83.5M | -82.5% |
| FY2020 | -$45.7M | -137.7% |
| FY2019 | -$19.2M | -40.1% |
| FY2018 | -$13.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALXO financial trends
ALXO RevenueALXO Net marginALXO Gross profitALXO Gross marginALXO Operating incomeALXO Operating marginALXO Operating cash flowALXO Free cash flowALXO Capital expendituresALXO Return on equityALXO Stock buybacksALXO Dividends paidALXO Total assetsALXO Total liabilitiesALXO Shareholders’ equityALXO overview →